Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/cannabinoid-system-in-the-skin-a-possible-target-for-future-therapies-Y0vmGTR9EF
References (131)
-
E. Berdyshev, P. Schmid, Zigang Dong, Harald Schmid (2000)
Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells.The Biochemical journal, 346 Pt 2
-
Yong-yao Cui, B. D'Agostino, Paul‐André Risse, G. Marrocco, E. Naline, Yong Zhang, Hong-Zhuan Chen, O. Finance, M. Rinaldi-Carmona, F. Rossi, C. Advenier (2007)
Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.European journal of pharmacology, 573 1-3
-
M. Caterina, M. Schumacher, M. Tominaga, Tobias Rosen, J. Levine, D. Julius (1997)
The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 389
-
A. Ellert-Miklaszewska, W. Grajkowska, Konrad Gabrusiewicz, B. Kamińska, L. Konarska (2007)
Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumorsBrain Research, 1137
-
A. Munson, L. Harris, M. Friedman, W. Dewey, R. Carchman (1975)
Antineoplastic activity of cannabinoids.Journal of the National Cancer Institute, 55 3
-
E. Berdyshev, E. Boichot, N. Germain, Nathalie Allain, Jean-Pierre Anger, Vincent Lagente (1997)
Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells.European journal of pharmacology, 330 2-3
-
S. Taddei (2005)
Evolving the concept of regulation of vascular tone in humansBritish Journal of Pharmacology, 146
-
T. Klein (2005)
Cannabinoid-based drugs as anti-inflammatory therapeuticsNature Reviews Immunology, 5
-
T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, K. Itoh, A. Yamashita, K. Waku (1995)
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.Biochemical and biophysical research communications, 215 1
-
J. Sipe, N. Arbour, A. Gerber, E. Beutler (2005)
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disordersJournal of Leukocyte Biology, 78
-
Susan Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. Petrocellis, F. Fezza, M. Tognetto, Timothy Petros, Jocelyn Krey, Constance Chu, Jeffrey Miller, S. Davies, P. Geppetti, J. Walker, V. Marzo (2002)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptorsProceedings of the National Academy of Sciences of the United States of America, 99
-
S. Jaggar, F. Hasnie, S. Sellaturay, A. Rice (1998)
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory painPain, 76
-
C. Labuda, Michael Koblish, P. Little (2005)
Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.European journal of pharmacology, 527 1-3
-
A. Patwardhan, N. Jeske, Theodore Price, N. Gamper, A. Akopian, K. Hargreaves (2006)
The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin.Proceedings of the National Academy of Sciences of the United States of America, 103 30
-
J. Tang, G. Lancz, S. Specter, H. Bullock (1992)
Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1.International journal of immunopharmacology, 14 2
-
D. Karanian, Queenie Brown, A. Makriyannis, T. Kosten, B. Bahr (2005)
Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against ExcitotoxicityThe Journal of Neuroscience, 25
-
M. Maccarrone, M. Rienzo, N. Battista, V. Gasperi, P. Guerrieri, A. Rossi, A. Finazzi-Agrò (2003)
The Endocannabinoid System in Human KeratinocytesJournal of Biological Chemistry, 278
-
Casanova (2003)
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptorsJ Clin Invest, 111
-
M. Salzet, C. Breton, T. Bisogno, V. Marzo (2000)
Comparative biology of the endocannabinoid system possible role in the immune response.European journal of biochemistry, 267 16
-
P. Pacher, S. Batkai, G. Kunos (2006)
The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 58
-
C. Lombard, M. Nagarkatti, P. Nagarkatti (2005)
Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells.Leukemia research, 29 8
-
D. Sagar, Dave Kendall, V. Chapman (2008)
Inhibition of fatty acid amide hydrolase produces PPAR‐α‐mediated analgesia in a rat model of inflammatory painBritish Journal of Pharmacology, 155
-
J. Tang, G. Lancz, S. Specter (1993)
Delta-9-tetrahydrocannabinol-(THC)-mediated inhibition of macrophage macromolecular metabolism is antagonized by human serum proteins and by cell surface proteins.International journal of immunopharmacology, 15 6
-
B. Veronesi, M. Oortgiesen (2006)
The TRPV1 receptor: target of toxicants and therapeutics.Toxicological sciences : an official journal of the Society of Toxicology, 89 1
-
G. Cabral, D. Pettit (1998)
Drugs and immunity: cannabinoids and their role in decreased resistance to infectious diseaseJournal of Neuroimmunology, 83
-
W. Devane, F. Dysarz, M. Johnson, L. Melvin, A. Howlett (1988)
Determination and characterization of a cannabinoid receptor in rat brain.Molecular pharmacology, 34 5
-
M. Casanova, C. Blázquez, J. Martínez‐Palacio, Concepción Villanueva, M. Fernández-Aceñero, J. Huffman, J. Jorcano, M. Guzmán (2003)
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.The Journal of clinical investigation, 111 1
-
P. Movahed, V. Evilevitch, T. Andersson, B. Jönsson, P. Wollmer, P. Zygmunt, E. Högestätt (2005)
Vascular effects of anandamide and N‐acylvanillylamines in the human forearm and skin microcirculationBritish Journal of Pharmacology, 146
-
T. Freund, I. Katona, D. Piomelli (2003)
Role of endogenous cannabinoids in synaptic signaling.Physiological reviews, 83 3
-
M. Herkenham, Abigail Lynn, M.Ross Johnson, L. Melvin, B. Costa, K. Rice (1991)
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, 11
-
M. Bouaboula, S. Hilairet, J. Marchand, L. Fajas, G. Fur, P. Casellas (2005)
Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.European journal of pharmacology, 517 3
-
E. Onaivi, A. Chakrabarti, G. Chaudhuri (1996)
Cannabinoid receptor genesProgress in Neurobiology, 48
-
S. Akerman, Holger Kaube, P. Goadsby (2004)
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptorsBritish Journal of Pharmacology, 142
-
V. Natarajan, P. Schmid, P. Reddy, H. Schmid (1984)
Catabolism of N‐Acylethanolamine Phospholipids by Dog Brain PreparationsJournal of Neurochemistry, 42
-
M. Namazi (2005)
Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunitionJournal of the European Academy of Dermatology and Venereology, 19
-
M. Elphick, M. Egertová (2001)
The neurobiology and evolution of cannabinoid signalling.Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 356 1407
-
L. Facci, R. Toso, S. Romanello, A. Buriani, S. Skaper, A. Leon (1995)
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.Proceedings of the National Academy of Sciences of the United States of America, 92
-
S. Elmes, M. Jhaveri, D. Smart, D. Kendall, V. Chapman (2004)
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic painEuropean Journal of Neuroscience, 20
-
D. Shire, C. Carillon, M. Kaghad, B. Calandra, M. Rinaldi-Carmona, G. Fur, D. Caput, P. Ferrara (1995)
An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*)The Journal of Biological Chemistry, 270
-
F. Scarampella, F. Abramo, C. Noli (2001)
Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study.Veterinary dermatology, 12 1
-
C. Lombard, R. Mckallip, P. Hylemon, P. Nagarkatti, M. Nagarkatti (2003)
Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.Clinical immunology, 109 2
-
L. Johanek, D. Simone (2004)
Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injuryPain, 109
-
J. Komorowski, H. Stępień (2007)
[The role of the endocannabinoid system in the regulation of endocrine function and in the control of energy balance in humans].Postepy higieny i medycyny doswiadczalnej, 61
-
J. Palazuelos, N. Davoust, B. Julien, E. Hatterer, T. Aguado, R. Mechoulam, C. Benito, J. Romero, Augusto Silva, M. Guzmán, S. Nataf, I. Galve-Roperh (2008)
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.The Journal of biological chemistry, 283 19
-
A. Paradisi, N. Pasquariello, D. Barcaroli, M. Maccarrone (2008)
Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner*Journal of Biological Chemistry, 283
-
E. Högestätt, P. Zygmunt (2002)
Cardiovascular pharmacology of anandamide.Prostaglandins, leukotrienes, and essential fatty acids, 66 2-3
-
Y. Sun, Stephen Alexander, D. Kendall, A. Bennett (2006)
Cannabinoids and PPARalpha signalling.Biochemical Society transactions, 34 Pt 6
-
N. Buckley, D. Burbridge, M. Buranapramest, Tanya Ferguson, Renee Paau (2006)
Experimental methods to study the role of the peripheral cannabinoid receptor in immune function.Methods in molecular medicine, 123
-
B. Cravatt, K. Demarest, M. Patricelli, M. Bracey, Dan Giang, B. Martin, A. Lichtman (2001)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseProceedings of the National Academy of Sciences of the United States of America, 98
-
E. Berdyshev, E. Boichot, M. Corbel, N. Germain, V. Lagente (1998)
Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice.Life sciences, 63 8
-
J. Schlosburg, S. Kinsey, A. Lichtman (2009)
Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and InflammationThe AAPS Journal, 11
-
Saori Oka, Shin Yanagimoto, S. Ikeda, Maiko Gokoh, S. Kishimoto, K. Waku, Y. Ishima, T. Sugiura (2005)
Evidence for the Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in 12-O-Tetradecanoylphorbol-13-acetate-induced Acute Inflammation in Mouse Ear*Journal of Biological Chemistry, 280
-
C. Lombard, M. Nagarkatti, P. Nagarkatti (2007)
CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.Clinical immunology, 122 3
-
A. Lynn, Miles Herkenham (1994)
Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.The Journal of pharmacology and experimental therapeutics, 268 3
-
S. Ständer, M. Schmelz, D. Metze, T. Luger, R. Rukwied (2005)
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin.Journal of dermatological science, 38 3
-
J. Schlosburg, D. Boger, B. Cravatt, A. Lichtman (2009)
Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for PruritusJournal of Pharmacology and Experimental Therapeutics, 329
-
C. Breivogel, G. Griffin, V. Marzo, B. Martin (2001)
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.Molecular pharmacology, 60 1
-
S. Kuenzli, J. Saurat (2004)
Peroxisome proliferator-activated receptors as new molecular targets in psoriasis.Current drug targets. Inflammation and allergy, 3 2
-
P. Reed (1980)
Oesophageal reflux.The Practitioner, 224 1342
-
Thompson (2005)
Cutaneous melanomaLancet, 365
-
Gautham Rao, Wei Zhang, N. Kaminski (2004)
Cannabinoid receptor‐mediated regulation of intracellular calcium by Δ9‐tetrahydrocannabinol in resting T cellsJournal of Leukocyte Biology, 75
-
A. Nakamura, H. Shiomi (1999)
Recent advances in neuropharmacology of cutaneous nociceptors.Japanese journal of pharmacology, 79 4
-
E. Onaivi, C. Leonard, H. Ishiguro, Ping-Wu Zhang, Zhicheng Lin, B. Akinshola, G. Uhl (2002)
Endocannabinoids and cannabinoid receptor geneticsProgress in Neurobiology, 66
-
S. Childers, S. Deadwyler (1996)
Role of cyclic AMP in the actions of cannabinoid receptors.Biochemical pharmacology, 52 6
-
W. Devane (1994)
New dawn of cannabinoid pharmacology.Trends in pharmacological sciences, 15 2
-
L. Petrocellis, T. Bisogno, M. Maccarrone, John Davis, A. Finazzi-Agrò, V. Marzo (2001)
The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism*The Journal of Biological Chemistry, 276
-
B. Costa, S. Conti, G. Giagnoni, M. Colleoni (2002)
Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo‐oxygenase systemsBritish Journal of Pharmacology, 137
-
M. Karsak, E. Gaffal, Rahul Date, Lihua Wang-Eckhardt, J. Rehnelt, S. Petrosino, K. Starowicz, Regina Steuder, E. Schlicker, B. Cravatt, R. Mechoulam, R. Buettner, S. Werner, V. Marzo, T. Tüting, A. Zimmer (2007)
Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid SystemScience, 316
-
A. Lichtman, D. Leung, C. Shelton, A. Saghatelian, C. Hardouin, D. Boger, B. Cravatt (2004)
Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and SelectivityJournal of Pharmacology and Experimental Therapeutics, 311
-
R. Lau, D. Tubergen, M. Barr, E. Domino, N. Benowitz, R. Jones (1976)
Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol.Science, 192 4241
-
M. Bifulco, V. Marzo (2002)
Targeting the endocannabinoid system in cancer therapy: A call for further researchNature Medicine, 8
-
B. Costa, A. Trovato, M. Colleoni, G. Giagnoni, E. Zarini, T. Croci (2005)
Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nervePain, 116
-
Yan Sun, Stephen Alexander, D. Kendall, A. Bennett (2006)
Cannabinoids and PPARα signallingBiochemical Society Transactions, 34
-
Xuefeng Zhang, Jian Wang, G. Kunos, J. Groopman (2007)
Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.Cancer research, 67 15
-
L. Matsuda, S. Lolait, M. Brownstein, A. Young, T. Bonner (1990)
Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 346
-
J. Ahluwalia, L. Urbán, S. Bevan, I. Nagy (2003)
Anandamide regulates neuropeptide release from capsaicin‐sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitroEuropean Journal of Neuroscience, 17
-
M. Hoehe, L. Caenazzo, M. Martinez, W. Hsieh, W. Modi, E. Gershon, T. Bonner (1991)
Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15.The New biologist, 3 9
-
A. Brown (2007)
Novel cannabinoid receptorsBritish Journal of Pharmacology, 152
-
B. Kaplan, Alison Springs, N. Kaminski (2008)
The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).Biochemical pharmacology, 76 6
-
B. Cravatt, A. Lichtman (2003)
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.Current opinion in chemical biology, 7 4
-
R. Paus, M. Schmelz, T. Bíró, M. Steinhoff (2006)
Frontiers in pruritus research: scratching the brain for more effective itch therapy.The Journal of clinical investigation, 116 5
-
J. Thompson, R. Scolyer, R. Kefford (2009)
Cutaneous melanoma in the era of molecular profilingThe Lancet, 374
-
W. Devane, L. Hanuš, A. Breuer, R. Pertwee, L. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, R. Mechoulam (1992)
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.Science, 258 5090
-
R. Russo, J. Loverme, G. Rana, G. D'Agostino, O. Sasso, A. Calignano, D. Piomelli (2007)
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.European journal of pharmacology, 566 1-3
-
M. Maccarrone (2006)
Fatty acid amide hydrolase: a potential target for next generation therapeutics.Current pharmaceutical design, 12 6
-
A. Ameri (1999)
The effects of cannabinoids on the brainProgress in Neurobiology, 58
-
V. Natarajan, P. Schmid, P. Reddy, M. Zuzarte‐Augustin, H. Schmid (1983)
Biosynthesis of N‐Acylethanolamine Phospholipids by Dog Brain PreparationsJournal of Neurochemistry, 41
-
Y. Gaoni, R. Mechoulam (1971)
The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish.Journal of the American Chemical Society, 93 1
-
N. Boulais, L. Miséry (2008)
The epidermis: a sensory tissue.European journal of dermatology : EJD, 18 2
-
C. Blázquez, A. Carracedo, L. Barrado, Pedro Real, José Fernández‐Luna, G. Velasco, Marcos Malumbres, M. Guzmán (2006)
Cannabinoid receptors as novel targets for the treatment of melanomaThe FASEB Journal, 20
-
R. Mechoulam, S. Ben-Shabat, L. Hanuš, M. Ligumsky, N. Kaminski, A. Schatz, A. Gopher, S. Almog, B. Martin, D. Compton, R. Pertwee, G. Griffin, M. Bayewitch, J. Barg, Z. Vogel (1995)
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.Biochemical pharmacology, 50 1
-
K. Jonsson, E. Persson, C. Fowler (2006)
The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.Life sciences, 78 6
-
S. Ständer, Reinhardt Hw, T. Luger (2006)
[Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 57 9
-
R. Rukwied, A. Watkinson, F. McGlone, M. Dvorak (2003)
Cannabinoid agonists attenuate capsaicin-induced responses in human skinPain, 102
-
(2003)
protein-1, and transglutaminase -
Yan Sun, A. Bennett (2007)
Cannabinoids: A New Group of Agonists of PPARsPPAR Research, 2007
-
Y. Ouyang, S. Hwang, S. Han, N. Kaminski (1998)
Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.Molecular pharmacology, 53 4
-
S. Kishimoto, M. Muramatsu, Maiko Gokoh, Saori Oka, K. Waku, T. Sugiura (2005)
Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells.Journal of biochemistry, 137 2
-
Lisa Matsuda (1997)
Molecular aspects of cannabinoid receptors.Critical reviews in neurobiology, 11 2-3
-
B. Basavarajappa (2007)
Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Current neuropharmacology, 5 2
-
S. Boyd (2006)
The Endocannabinoid SystemPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 26
-
J. Long, Weiwei Li, L. Booker, J. Burston, S. Kinsey, J. Schlosburg, F. Pavón, A. Serrano, D. Selley, L. Parsons, A. Lichtman, B. Cravatt (2008)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effectsNature chemical biology, 5
-
S. Sarfaraz, V. Adhami, D. Syed, F. Afaq, H. Mukhtar (2008)
Cannabinoids for cancer treatment: progress and promise.Cancer research, 68 2
-
S. Mazzari, R. Canella, L. Petrelli, G. Marcolongo, A. Leon (1996)
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.European journal of pharmacology, 300 3
-
D. Baker, G. Pryce, Wayne Davies, C. Hiley (2006)
In silico patent searching reveals a new cannabinoid receptor.Trends in pharmacological sciences, 27 1
-
J. Szepietowski, A. Reich, T. Szepietowski (2005)
Emollients With Endocannabinoids in the Treatment of Uremic Pruritus: Discussion of the Therapeutic OptionsTherapeutic Apheresis and Dialysis, 9
-
P. Staton, J. Hatcher, D. Walker, A. Morrison, Ellen Shapland, J. Hughes, Elizabeth Chong, P. Mander, P. Green, A. Billinton, M. Fulleylove, Hilary Lancaster, Jason Smith, Leigh Bailey, A. Wise, Andrew Brown, J. Richardson, I. Chessell (2008)
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic painPAIN, 139
-
J. Szepietowski, T. Szepietowski, A. Reich (2005)
Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study.Acta dermatovenerologica Croatica : ADC, 13 2
-
A. Tahim, P. Sántha, P. Sántha, Istvan Nagy (2005)
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neuronsNeuroscience, 136
-
B. Costa, F. Comelli, Isabella Bettoni, M. Colleoni, G. Giagnoni (2008)
The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factorsPAIN, 139
-
S. Munro, K. Thomas, Muna Abu-Shaar (1993)
Molecular characterization of a peripheral receptor for cannabinoidsNature, 365
-
M. Srivastava, B. Srivastava, B. Brouhard (1998)
Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.Immunopharmacology, 40 3
-
V. Lees, J. Briggs (1993)
Cutaneous melanoma.Journal of the American Academy of Dermatology, 29 2 Pt 1
-
D. Baker, S. Jackson, G. Pryce (2007)
Cannabinoid control of neuroinflammation related to multiple sclerosisBritish Journal of Pharmacology, 152
-
M. Maccarrone, S. Rossi, M. Bari, V. Chiara, F. Fezza, A. Musella, V. Gasperi, C. Prosperetti, G. Bernardi, A. Finazzi-Agrò, B. Cravatt, D. Centonze (2008)
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatumNature Neuroscience, 11
-
H. Tsao, M. Atkins, A. Sober (2004)
Management of cutaneous melanoma.The New England journal of medicine, 351 10
-
M. Jhaveri, D. Richardson, V. Chapman (2007)
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory painBritish Journal of Pharmacology, 152
-
M. Maccarrone, M. Bari, T. Lorenzon, T. Bisogno, V. Marzo, A. Finazzi-Agrò (2000)
Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide*The Journal of Biological Chemistry, 275
-
S. Ständer, E. Weisshaar, T. Luger (2008)
Neurophysiological and neurochemical basis of modern pruritus treatmentExperimental Dermatology, 17
-
T. Klein, C. Newton, K. Larsen, Lily Lu, Izabella Perkins, L. Nong, H. Friedman (2003)
The cannabinoid system and immune modulationJournal of Leukocyte Biology, 74
-
B. Eberlein, C. Eicke, H. Reinhardt, J. Ring (2007)
Adjuvant treatment of atopic eczema: assessment of an emollient containing N‐palmitoylethanolamine (ATOPA study)Journal of the European Academy of Dermatology and Venereology, 22
-
S. Galiègue, S. Mary, J. Marchand, D. Dussossoy, D. Carrière, P. Carayon, M. Bouaboula, D. Shire, G. Fur, P. Casellas (1995)
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.European journal of biochemistry, 232 1
-
Y. Ueda, Naoki Miyagawa, Tomoko Matsui, Tetsudo Kaya, H. Iwamura (2005)
Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.European journal of pharmacology, 520 1-3
-
Michelle Glass, A. Dellen, Colin Blakemore, A. Hannan, R. Faull (2004)
Delayed onset of huntington′s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptorsNeuroscience, 123
-
E. Fride (2004)
The endocannabinoid-CB(1) receptor system in pre- and postnatal life.European journal of pharmacology, 500 1-3
-
Duo Zheng, A. Bode, Qing Zhao, Yong-Yeon Cho, Feng Zhu, Weiya Ma, Z. Dong (2008)
The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development.Cancer research, 68 10
-
Yakov Chudnovsky, P. Khavari, A. Adams (2005)
Melanoma genetics and the development of rational therapeutics.The Journal of clinical investigation, 115 4
-
MM Dvorak, Allan Watkinson, Francis McGlone, Roman Rukwied (2003)
Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skinInflammation Research, 52
-
M. Srivastava, B. Srivastava, B. Brouhard (1998)
Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cellsImmunopharmacology, 40
-
J. Wilkinson, E. Williamson (2007)
Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.Journal of dermatological science, 45 2
-
A. Porter, J. Sauer, M. Knierman, G. Becker, M. Berna, J. Bao, G. Nomikos, Petra Carter, F. Bymaster, Andrea Leese, C. Felder (2002)
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.The Journal of pharmacology and experimental therapeutics, 301 3
- Publisher
- Wiley
- Copyright
- © 2009 John Wiley & Sons A/S
- ISSN
- 0906-6705
- eISSN
- 1600-0625
- DOI
- 10.1111/j.1600-0625.2009.00923.x
- pmid
- 19664006
- Publisher site
- See Article on Publisher Site
Abstract
Abstract: Cannabinoids and their derivatives are group of more than 60 biologically active chemical agents, which have been used in natural medicine for centuries. The major agent of exogenous cannabinoids is Δ9‐tetrahydrocannabinol (Δ9‐THC), natural psychoactive ingredient of marijuana. However, psychoactive properties of these substances limited their use as approved medicines. Recent discoveries of endogenous cannabinoids (e.g. arachidonoylethanolamide, 2‐arachidonoylglycerol or palmithyloethanolamide) and their receptors initiated discussion on the role of cannabinoid system in physiological conditions as well as in various diseases. Based on the current knowledge, it could be stated that cannabinoids are important mediators in the skin, however their role have not been well elucidated yet. In our review, we summarized the current knowledge about the significant role of the cannabinoid system in the cutaneous physiology and pathology, pointing out possible future therapeutic targets.
Journal
Experimental Dermatology – Wiley
Published: Aug 1, 2009